Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ACER Acer Therapeutics Inc

0,90

0,00 (0,00%)

23 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
d500239dars.pdf

Acer Therapeutics (NASDAQ:ACER)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Acer Therapeutics Charts.

Acer Therapeutics (NASDAQ:ACER)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Acer Therapeutics Charts.

News Acer Therapeutics Inc.

Form 425 - Prospectuses and communications, business combinations
Mittwoch 8 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 2 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 2 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 2 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
Donnerstag 2 November 2023 (7 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 30 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form DEFM14A - Definitive proxy statement relating to merger or acquisition
Dienstag 10 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Donnerstag 31 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 31 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
Donnerstag 31 August 2023 (9 Monate vor) • GlobeNewswire Inc.

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Mittwoch 30 August 2023 (9 Monate vor) • GlobeNewswire Inc.

Weitere Acer Therapeutics Inc. News-Artikel

Spdr Msci Acwi Ucits Etf

NLBNPIT1ZYR2 20991231 76...

Credit Agricole CIB Fina...

NLBNPIT1VPE7 20240621 40

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen